Watchlist Price Alert

Rapport Therapeutics Inc.... (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

11.08

0.13 (1.19%)

At close: Jun 18, 2025, 11:35 AM

Rapport Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Net Income	-79.7M	-78.31M	-71.85M	-63.02M	-51.31M	-34.79M	-21.27M	-12.56M	-6.15M
Depreciation & Amortization	931K	839K	632K	436K	249K	112K	59K	36K	15K
Stock-Based Compensation	12.78M	10.23M	8.03M	5.7M	4.29M	3.52M	2.53M	1.67M	723K
Other Working Capital	3.8M	647K	1.17M	-410K	-1.44M	1.29M	75K	-1.58M	-422K
Other Non-Cash Items	-2.73M	5.63M	5.07M	10.75M	9.64M	3.06M	2.89M	2.77M	1.78M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.5M	1.34M	1.94M	948K	-83K	2.65M	708K	-1.58M	-422K
Operating Cash Flow	-67.45M	-64.83M	-60.74M	-49.75M	-39.99M	-27.18M	-16.82M	-11.4M	-4.8M
Capital Expenditures	-1.62M	-2.4M	-3.62M	-3.53M	-2.65M	-1.64M	-199K	-147K	-61K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-380.17M	-381.3M	-373.97M	-260.45M	-122.03M	-77.22M	n/a	n/a	n/a
Sales Maturities Of Investments	270.41M	209.8M	93.08M	36.24M	3.95M	n/a	n/a	n/a	n/a
Other Investing Acitivies	4.21M	3.77M	3.77M	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-107.18M	-170.14M	-280.73M	-227.74M	-120.72M	-78.86M	-199K	-147K	-61K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	296K	7K	-134K	-76K	-399K	-134K	n/a	-58K	-18K
Financial Cash Flow	157.97M	221.63M	221.48M	308.23M	148.79M	145.14M	145.28M	59.92M	60.01M
Net Cash Flow	-16.66M	-13.34M	-119.99M	30.74M	-11.93M	39.09M	128.25M	48.37M	55.14M
Free Cash Flow	-69.07M	-67.23M	-64.36M	-53.28M	-42.64M	-28.82M	-17.02M	-11.55M	-4.86M